Stockreport

Shareholders May Be More Conservative With Kronos Bio, Inc.'s (NASDAQ:KRON) CEO Compensation For Now [Yahoo! Finance]

Kronos Bio, Inc.  (KRON) 
PDF The total compensation is 51% higher than the average for the industry Kronos Bio's three-year loss to shareholders was 96% while its EPS grew by 19% over the past th [Read more]